Connable Office’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
Connable Office's CNMD Position: Q3 2026 in Review
Connable Office reduced its CONMED (CNMD) stake by 9.7% in Q3 2026, selling an estimated $31.6K and leaving 6,457 shares worth $299K. The position accounts for 0.03% of the portfolio, ranked #184.
Connable Office first reported a position in CNMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $707K in Q1 2022. 213 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.
- Connable Office held 6,457 shares of CONMED worth $299K as of Q3 2026.
- Connable Office sold 690 CONMED shares in Q3 2026, an estimated $31.6K.
- CONMED made up 0.03% of Connable Office's portfolio in Q3 2026, its #184 holding.
- Connable Office first reported a position in CONMED in Q3 2020 and has held it in 24 quarters since.
- Connable Office's CONMED position peaked at $707K in Q1 2022.
- 213 funds tracked by Wall St. Rank held CONMED as of Q3 2026.
Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.